Effectiveness of early chemotherapy treatment in anaplastic astrocytoma patients

A. Silvani, A. Salmaggi, A. Pozzi, L. Fariselli, A. Franzini, A. Boiardi

Research output: Contribution to journalArticle

Abstract

There are limited data in the literature concerning chemotherapy trials for the treatment of anaplastic astrocytomas. Forty-one anaplastic astrocytoma patients, operated on during the period 1988 to 1993 at the Neurological Institute of Milan, received 4-5 cycles of chemotherapy (BCNU + cisplatin), subsequently radiotherapy (median dose 56.5 Gy), and finally a second-line chemotherapy protocol at recurrence (procarbazine, vincristine, lomustine). The aim of the study was to evaluate the effectiveness of the planned protocol, considering the time to tumor progression and the survival time. The group of anaplastic astrocytoma patients was compared with a homogeneous group of 39 anaplastic astrocytoma patients treated only with radiotherapy after surgery. The median time to tumor progression of patients on the protocol was 24.5 months. The median survival time for anaplastic astrocytoma patients treated with our scheduled protocol or only with radiotherapy was 38.8 and 21 months, respectively. However, our data need to be confirmed by large randomized clinical studies.

Original languageEnglish
Pages (from-to)424-428
Number of pages5
JournalTumori
Volume81
Issue number6
Publication statusPublished - 1995

Fingerprint

Astrocytoma
Drug Therapy
Radiotherapy
Lomustine
Procarbazine
Therapeutics
Carmustine
Survival
Vincristine
Cisplatin
Neoplasms
Recurrence

Keywords

  • anaplastic astrocytomas
  • chemotherapy
  • cisplatin

ASJC Scopus subject areas

  • Cancer Research

Cite this

Effectiveness of early chemotherapy treatment in anaplastic astrocytoma patients. / Silvani, A.; Salmaggi, A.; Pozzi, A.; Fariselli, L.; Franzini, A.; Boiardi, A.

In: Tumori, Vol. 81, No. 6, 1995, p. 424-428.

Research output: Contribution to journalArticle

Silvani, A. ; Salmaggi, A. ; Pozzi, A. ; Fariselli, L. ; Franzini, A. ; Boiardi, A. / Effectiveness of early chemotherapy treatment in anaplastic astrocytoma patients. In: Tumori. 1995 ; Vol. 81, No. 6. pp. 424-428.
@article{0e0ea0fd7ab042058c268740de165a27,
title = "Effectiveness of early chemotherapy treatment in anaplastic astrocytoma patients",
abstract = "There are limited data in the literature concerning chemotherapy trials for the treatment of anaplastic astrocytomas. Forty-one anaplastic astrocytoma patients, operated on during the period 1988 to 1993 at the Neurological Institute of Milan, received 4-5 cycles of chemotherapy (BCNU + cisplatin), subsequently radiotherapy (median dose 56.5 Gy), and finally a second-line chemotherapy protocol at recurrence (procarbazine, vincristine, lomustine). The aim of the study was to evaluate the effectiveness of the planned protocol, considering the time to tumor progression and the survival time. The group of anaplastic astrocytoma patients was compared with a homogeneous group of 39 anaplastic astrocytoma patients treated only with radiotherapy after surgery. The median time to tumor progression of patients on the protocol was 24.5 months. The median survival time for anaplastic astrocytoma patients treated with our scheduled protocol or only with radiotherapy was 38.8 and 21 months, respectively. However, our data need to be confirmed by large randomized clinical studies.",
keywords = "anaplastic astrocytomas, chemotherapy, cisplatin",
author = "A. Silvani and A. Salmaggi and A. Pozzi and L. Fariselli and A. Franzini and A. Boiardi",
year = "1995",
language = "English",
volume = "81",
pages = "424--428",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "6",

}

TY - JOUR

T1 - Effectiveness of early chemotherapy treatment in anaplastic astrocytoma patients

AU - Silvani, A.

AU - Salmaggi, A.

AU - Pozzi, A.

AU - Fariselli, L.

AU - Franzini, A.

AU - Boiardi, A.

PY - 1995

Y1 - 1995

N2 - There are limited data in the literature concerning chemotherapy trials for the treatment of anaplastic astrocytomas. Forty-one anaplastic astrocytoma patients, operated on during the period 1988 to 1993 at the Neurological Institute of Milan, received 4-5 cycles of chemotherapy (BCNU + cisplatin), subsequently radiotherapy (median dose 56.5 Gy), and finally a second-line chemotherapy protocol at recurrence (procarbazine, vincristine, lomustine). The aim of the study was to evaluate the effectiveness of the planned protocol, considering the time to tumor progression and the survival time. The group of anaplastic astrocytoma patients was compared with a homogeneous group of 39 anaplastic astrocytoma patients treated only with radiotherapy after surgery. The median time to tumor progression of patients on the protocol was 24.5 months. The median survival time for anaplastic astrocytoma patients treated with our scheduled protocol or only with radiotherapy was 38.8 and 21 months, respectively. However, our data need to be confirmed by large randomized clinical studies.

AB - There are limited data in the literature concerning chemotherapy trials for the treatment of anaplastic astrocytomas. Forty-one anaplastic astrocytoma patients, operated on during the period 1988 to 1993 at the Neurological Institute of Milan, received 4-5 cycles of chemotherapy (BCNU + cisplatin), subsequently radiotherapy (median dose 56.5 Gy), and finally a second-line chemotherapy protocol at recurrence (procarbazine, vincristine, lomustine). The aim of the study was to evaluate the effectiveness of the planned protocol, considering the time to tumor progression and the survival time. The group of anaplastic astrocytoma patients was compared with a homogeneous group of 39 anaplastic astrocytoma patients treated only with radiotherapy after surgery. The median time to tumor progression of patients on the protocol was 24.5 months. The median survival time for anaplastic astrocytoma patients treated with our scheduled protocol or only with radiotherapy was 38.8 and 21 months, respectively. However, our data need to be confirmed by large randomized clinical studies.

KW - anaplastic astrocytomas

KW - chemotherapy

KW - cisplatin

UR - http://www.scopus.com/inward/record.url?scp=0029554144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029554144&partnerID=8YFLogxK

M3 - Article

C2 - 8804468

AN - SCOPUS:0029554144

VL - 81

SP - 424

EP - 428

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 6

ER -